DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY. (2026). International Research Journal of Pharmacy, 17(3), 1-11. https://doi.org/10.56802/e8qzhp89